:L-asparaginase

Rajan K Tripathy1, J Anakha1, Abhay H Pande1

  • 1Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali 160062, Punjab, India.

概括

本综述探讨了L-asparaginase (ASNase) 生物改善剂用于急性淋巴细胞白血病 (ALL) 治疗. 开发改进的ASNase变体旨在提高疗效,降低毒性,并延长半衰期以获得更好的患者结果.